2017 GSR Annual Meeting
June 2-4, 2017
Ritz-Carlton, Reynolds Plantation
Aryeh Fischer, MD - Dr. Aryeh Fischer is Associate Professor of Medicine at the University of Colorado School of
Medicine with a primary appointment within the Division of Rheumatology and a secondary appointment in the Division of Pulmonary
Sciences and Critical Care Medicine within the Department of Medicine.
His specific area of clinical and research expertise is within systemic sclerosis and autoimmune associated lung diseases, and
autoimmune interstitial lung disease in particular. He has developed clinical expertise with patients referred nationally
for evaluation of autoimmune lung disease. Dr. Fischer has served as an invited lecturer on autoimmune and interstitial
lung diseases at numerous national and international pulmonary and rheumatology conferences and has numerous original
research publications, review articles, and textbook chapters dealing with autoimmune interstitial lung disease.
Jonathan Kay, MD - Jonathan Kay, MD, is Professor of Medicine at the University of Massachusetts Medical School
and a physician at UMass Memorial Medical Center in Worcester, where he directs clinical research in the Division of Rheumatology. He
received his medical degree from the University of California School of Medicine in San Francisco, California. He then completed
an internship and residency at the Hospital of the University of Pennsylvania in Philadelphia and fellowships in rheumatology
and immunology at The Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts. He is a Fellow of the
American College of Rheumatology and of the American College of Physicians. He is also an ad hoc reviewer for many journals,
and a member of the editorial boards of Best Practice and Research Clinical Rheumatology and the Journal of Clinical
Rheumatology, and of the Advisory Board of Arthritis Research and Therapy. He was Section Editor of "Systemic Disorders
with Rheumatic Manifestations" for Current Opinion in Rheumatology. His clinical interests span the spectrum of
rheumatic diseases, with special interest in rheumatoid arthritis and other forms of inflammatory arthritis. He was a member
of the group that developed the 2010 ACR/EULAR Diagnostic and Classification Criteria for Rheumatoid Arthritis. He chairs
the Rheumatology Working Group and is a member of the Internal Medicine and Musculoskeletal Topic Advisory Groups for the
World Health Organization in its Revision of the International Classification of Diseases (ICD)-11. He has presented his
work at international lectures, and is the author of more than 100 journal articles and book chapters.
Philip Seo, MD - Dr. Philip Seo is an Assistant Professor in the Division of Rheumatology. A graduate of Harvard College
and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a
member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several
capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of
the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology.
His research interests are the assessment and treatment of ANCA-associated vasculitides, including Churg Strauss Syndrome,
Wegener's Granulomatosis, and Microscopic Polyangiitis.
Richard Silver, MD - Dr. Rick Silver is a Professor of Medicine and Pediatrics and has served as Director
of the Division of Rheumatology and Immunology since 1995. In 2007, he was named Distinguished University Professor, the
highest academic rank bestowed at MUSC. The Division has seen remarkable growth in all facets, including extramural
research funding, clinical services, and fellowship training during his tenure as Division Director. Under his direction,
the Division of Rheumatology has been consistently ranked among the top 20 programs by US News and World Report.
Dr. Silver's research interests center on scleroderma and, in particular, scleroderma lung disease, now a major cause of
death among patients with scleroderma. He and his colleagues were the first to utilize bronchoalveolar lavage (BAL) to
characterize scleroderma lung disease. He played an instrumental role in the design and development of the Scleroderma
Lung Study I and II. y. Dr. Silver helped to initiate and develop MUSC’s Pulmonary Hypertension Center and Sarcoidosis
Center. Dr. Silver serves as Associate Director of a Multidisciplinary Clinical Research Center (MCRC) for the Study of
Rheumatic Diseases in African-Americans funded by NIAMS.
Dr. Silver's clinical interests include scleroderma and scleroderma-related conditions, as well as childhood rheumatic
diseases. MUSC is one of the world’s leaders in clinical care and investigation of systemic sclerosis (scleroderma)
and scleroderma-like conditions, e.g., eosinophilic fasciitis and the eosinophilia-myalgia syndrome. MUSC also serves
as the state of South Carolina's only referral center for childhood rheumatic diseases. Dr. Silver has led the efforts
to coordinate care for children in South Carolina with rheumatic diseases for the past 32 years, and he continues to
provide clinical care and conduct clinical research with Dr. Tasha Ruth, whose primary appointment is in the Department